Vizient Forecasts Rising Healthcare Cost Pressures in 2027
Event summary
- Vizient projects 3.54% pharmacy inflation and 4.73% indirect spend inflation for 2027.
- Overall supply chain, capital, and purchased services inflation expected to reach 3.39%.
- Specialty medications like tirzepatide and semaglutide are driving self-administered pharmacy spending growth.
- Indirect spend categories such as IT security (8.50%) and construction (4.70%) face significant cost increases.
The big picture
Vizient's projections highlight the shifting dynamics in healthcare spending, with inflationary pressures extending beyond traditional clinical categories. The growing role of technology and infrastructure investments reflects broader industry trends toward digital transformation and operational resilience. As costs rise across pharmacy and indirect spend categories, healthcare organizations will need to balance financial sustainability with strategic growth initiatives.
What we're watching
- Pharmacy Cost Dynamics
- How the rising demand for specialty medications will impact overall pharmacy spending trends.
- Indirect Spend Growth
- Whether healthcare organizations can sustain investments in technology and infrastructure amid inflationary pressures.
- Operational Resilience
- The pace at which non-clinical services become strategic capabilities for healthcare providers.
Related topics